Apogee Therapeutics CMO Carl Dambkowski Sells Shares
Carl Dambkowski, Chief Medical Officer of Apogee Therapeutics, sold 3,860 shares of common stock on April 2, 2025, under a Rule 10b5-1 trading plan. The sales were executed at weighted average prices of $35.56, $37.03, and $37.59, resulting in a total sale amount of $139,801. Following these transactions, Dambkowski directly owns 247,173 shares of Apogee Therapeutics.
SEC Filing:
Apogee Therapeutics, Inc. [ APGE ] - Form 4 - Apr. 04, 2025
Reporter Name
Dambkowski Carl
Relationship
Chief Medical Officer
Type
Sell
Amount
$139,801
SEC Filing
Form 4